Immunotherapy in Non-Small Cell Lung Cancer Patients with Brain Metastases: Clinical Challenges and Future Directions

Immunotherapy in Non-Small Cell Lung Cancer Patients with Brain Metastases: Clinical Challenges and Future Directions

Immune checkpoint inhibitors have revolutionized the treatment landscape for patients with non-small cell lung cancers. Existing treatment paradigms for brain metastases in lung cancer patients leave patients with adverse neurocognitive function, poor quality of life, and dismal prognosis, thus high...

Full description

Bibliographic Details
Main Authors: Ranjan Pathak, Arya Amini, Addie Hill, Erminia Massarelli, Ravi Salgia
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Cancers
Subjects:
non-small cell lung cancer
brain metastasis
PD-1
PD-L1
immunotherapy
immune checkpoint inhibitors
Online Access:https://www.mdpi.com/2072-6694/13/14/3407

Internet

https://www.mdpi.com/2072-6694/13/14/3407

Similar Items